Corteva v. Monsanto: Transgenic Plant Patent Dispute Ends in Dismissal
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Corteva Agriscience, LLC v. Monsanto Company |
| Case Number | 1:22-cv-01046 (U.S. District Court for the District of Delaware) |
| Court | U.S. District Court for the District of Delaware |
| Duration | Aug 2022 – Jan 2026 3 years 5 months |
| Outcome | Stipulated Dismissal with Prejudice |
| Patents at Issue | |
| Accused Products | Transgenic plant implementations allegedly incorporating AAD-1 protein-encoding technology |
Case Overview
The Parties
⚖️ Plaintiff
Global leader in agricultural science, formed following the DowDuPont merger. Possesses an extensive seed and crop protection IP portfolio.
🛡️ Defendant
World’s most prominent agricultural biotechnology firm, known for its genetic trait platforms and herbicide-tolerance technologies.
Patents at Issue
This dispute centered on a critical innovation in herbicide-tolerant crop development:
- • US10947555B2 — Transgenic plants and plant cells comprising a recombinant polynucleotide encoding an AAD-1 protein.
Designing a similar trait?
Check if your plant technology might infringe this or related patents.
The Verdict & Legal Analysis
Outcome
The case was resolved via a **stipulated dismissal with prejudice**, filed jointly by Corteva Agriscience LLC and Monsanto Company / Bayer CropScience LLC pursuant to Fed. R. Civ. P. 41(a)(1) and 41(c). No damages award, royalty determination, or injunctive relief was entered.
Key Legal Issues
The underlying cause of action was a patent infringement action targeting Monsanto’s alleged use of technology covered by the AAD-1 transgenic plant patent. While the court did not issue a formal ruling on validity or infringement, several strategic dynamics likely shaped the resolution:
- • **Claim Construction Risk:** AAD-1 patent claims covering recombinant polynucleotides in transgenic systems can involve highly technical claim construction disputes, which influence litigation risk.
- • **Portfolio Cross-Licensing Dynamics:** The dismissal often signals a broader business resolution, such as a cross-licensing arrangement or commercial settlement between these agricultural biotech titans.
- • **With-Prejudice Significance:** Corteva surrendered its right to re-assert these specific claims against Bayer on US10947555B2, reflecting a negotiated exchange or strategic redirection of resources.
Filing a transgenic plant patent?
Learn from this case. Use AI to draft stronger claims for biotechnology that can withstand litigation.
Power Your Patent Strategy with PatSnap Eureka IP
From novelty searches to patent drafting, PatSnap Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in transgenic plant design. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View all related patents in the AAD-1 technology space
- See which companies are most active in plant patents
- Understand claim construction patterns for biotechnology
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
AAD-1 protein encoding technology for herbicide tolerance
Monitor Related Patents
In transgenic plant patent space
Strategic Dismissal
Preserving relationships, managing costs
✅ Key Takeaways
For Patent Attorneys & Litigators
Stipulated dismissal with prejudice under Rule 41(a)(1) and 41(c) is a common resolution mechanism in complex biotech patent disputes — understand the strategic implications of the with-prejudice designation.
Search related case law →Delaware remains the preferred venue for agriscience patent infringement litigation, known for its experienced judiciary.
Explore precedents →For R&D Teams
Conduct comprehensive FTO analysis before commercializing any transgenic trait involving AAD-1 or AOPP herbicide tolerance mechanisms.
Start FTO analysis for my product →Dismissal with prejudice does not invalidate US10947555B2 — the patent remains enforceable and a factor in future development.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.